Πέμπτη 4 Ιανουαρίου 2018

Immunotherapy: HLA-1 genotype influences response to checkpoint inhibitors.

Immunotherapy: HLA-1 genotype influences response to checkpoint inhibitors.

Nat Rev Clin Oncol. 2018 Jan 03;:

Authors: Sidaway P

PMID: 29297507 [PubMed - as supplied by publisher]



http://ift.tt/2ql1xHg

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου